The DNBSEQ User Group Meeting will be held at the Westin Boston Seaport District (Marina Ballroom I) on Tuesday, October 14, one day prior to the ASHG meeting. Whether you are a current DNBSEQ user or exploring the technology, you are welcome to join. The meeting will feature insights from users and partners, as well as updates on new products. The full-day program includes four sessions: DNBSEQ technology with a focus on sequencing applications, Stereo-seq technology highlighting spatial transcriptomics, data analysis with our partners NVIDIA and Google, and an exclusive tour with a sneak peek at the newest sequencer at our Customer Excellence Center in Boston.
Agenda
8:00–8:20 am
Check in & Breakfast
Sequencing & Analysis
DNBSEQ technology is a highly accurate, flexible, and cost-effective sequencing platform—ideal for high-throughput WGS and a variety of clinical and research applications. In this session, speakers will highlight the paradigm shift from targeted panels to WGS in precision medicine and share experiences applying DNBSEQ-T7 for NIPT and other clinical tests.
You will also hear about the new DNBSEQ-T1+, with talks covering its speed, scalability, and applications in single-cell sequencing, RNA modification profiling, and performance with partner technologies.
Our partners, NVIDIA and Google, will showcase faster, more scalable, and cost-effective pipelines for high-throughput sequencing.
Opening & Company intro
Rapid confirmation of NIPT results via amniotic and CVS testing using the DNBSEQ- T7
Peter Nagy, CMO, Praxis Genomics
High-quality and efficient WGS for clinical genetic testing with DNBSEQ-T7
Greice Krautz-Peterson, Director of Laboratory Operations, Variantyx
An end-to-end solution for multiplexed RNA modification profiling with AlidaBio’s EpiPlex platform
Gudrun Stengel, CEO & Co-Founder, Alida Bioscience
Benchmarking NVIDIA Parabricks GPU-accelerated workflows on DNBSEQ-T1+ and T7
Gary Burnett, Technical Marketing Engineer, NVIDIA
Google Deepvariant updated model for the DNBSEQ-T1+ and T7
Lucas Brambrink, Software engineer, Google
Break
DNBSEQ-T1+: fast, flexible, and scalable sequencing from discovery to clinical application
Enhanced single-cell RNA-Seq via Bio-Rad ddSEQ™ and DNBSEQ-T1+ sequencing platform
Patricia Schnepp, FBS, Bio-Rad Laboratories
High-quality performance of Takara Bio’s Shasta single-cell and Embgenix PGT-A technologies on DNBSEQ
Andrew Farmer, CSO, Takara Bioscience
Round Table Discussion
Spatial Transcriptomics
Stereo-seq technology has transformed spatial biology with its unique combination of true single-cell resolution, large capture area, and species-agnostic design. This session will feature diverse applications of Stereo-seq, including studies of the cancer microbiome, fruit fly behavior, and brain organoids.
Stereo-seq: Redefining What’s Possible in Spatial Transcriptomics
12:00–12:30 pm
Lunch
Longitudinal Multi-Omics Profiling of iPOP Samples Using High-Resolution Genomic, Transcriptomic and Proteomics with DNBSEQ
Jennifer Li-Pook-Than, Director of Precision Health and Engagement, Stanford University
Spatial Transcriptomic insights into tumor evolution
Khashayarsha Khazaie, Director of Spatial Biology Hybrid Core Laboratory, Mayo Clinic
Looking into the anti-social brain: spatial genomic insights into mechanisms of fruit fly behavior
Corbin Jones, Professor, Faculty Director Bioinformatic and Analytic Research Collaborative, UNC Chapel Hill
Local environmental heterogeneity: Advancing our understanding of the cancer microbiome
Andrew Bartko, Executive Director of the CMI, UCSD
Multi-transcriptomics integration of human-viral interactions using brain organoids
Elaine Lim, Assistant Professor, UMass Chan Medical School
2:20–2:35 pm
TBD
2:35–2:50 am
Break
Twice the unique reads for half the price using Stereo-seq OMNI with SEQuoia ribodepletion
Cissy Jiang, Sr. Product Manager, Bio-Rad Laboratories
Round Table Discussion
Exclusive Tour
Be the First to See Our New Sequencer
Join us at our Customer Experience Center (CEC) near Boston for an exclusive tour and a first look at our upcoming new sequencer, delivering faster speed and higher throughput than any other commercially available high-throughput sequencer.
Location: Suite 530, 175 Crossing Blvd, Framingham, MA 01702